Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity

2007 ◽  
Vol 25 (1) ◽  
pp. 46-52 ◽  
Author(s):  
Ena Segota ◽  
Tarek Mekhail ◽  
Thomas Olencki ◽  
Thomas E. Hutson ◽  
Robert Dreicer ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase Ii Trial ◽  
Interferon Α ◽  
Limited Efficacy

Phase II Trial of Low Dose γ -Interferon in Metastatic Renal Cell Carcinoma

1994 ◽  
Vol 152 (3) ◽  
pp. 841-845 ◽  
Author(s):  
Julie A. Ellerhorst ◽  
Robert G. Kilbourn ◽  
Robert J. Amato ◽  
Alexander A. Zukiwski ◽  
Elaine Jones ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Low Dose ◽  
Phase Ii Trial ◽  
Γ Interferon

An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma

2010 ◽  
Vol 66 (6) ◽  
pp. 1065-1070 ◽  
Author(s):  
Seiji Naito ◽  
Taiji Tsukamoto ◽  
Michiyuki Usami ◽  
Hiroyuki Fujimoto ◽  
Hideyuki Akaza
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Early Phase ◽  
Phase Ii Trial ◽  
Japanese Patients

scholarly journals Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma

Urology ◽  
2008 ◽  
Vol 72 (4) ◽  
pp. 898-902 ◽  
Author(s):  
Shanthi Marur ◽  
James Eliason ◽  
Lance K. Heilbrun ◽  
Brenda Dickow ◽  
Daryn W. Smith ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase Ii Trial ◽  
Weekly Docetaxel
Sign in / Sign up

Export Citation Format

Share Document